Charles River Laboratories International, Inc.

Charles River Laboratories International is a US drug development services company headquartered in Wilmington, Massachusetts. Its shares trade on the New York Stock Exchange under the ticker CRL, and the company is included in the S&P 500 index. The company was founded in 1947.

Charles River is a contract research organization that serves pharmaceutical and biotechnology companies at the preclinical research stage. The research models and services arm supplies research models such as laboratory rodents. The discovery and safety assessment arm carries out efficacy and safety testing of drug candidates. The manufacturing support arm offers quality testing and microbial solutions for biological products. The company is also working on alternatives to animal testing.

Those following Charles River Laboratories stock typically watch research and development spending by pharmaceutical and biotechnology companies, demand for preclinical studies, the funding environment, and regulators' policies on animal testing. On the CRL page at Lzzo.com, the share price is shown in US dollars, and the page includes a price chart and technical indicators.